Related Experiment Video
Updated: Aug 13, 2026
10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
A cell-state-centric view of inherited ESCC risk
1Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Cell Reports
|August 11, 2026
Summary
This study identifies invasive epithelial cells as key to inherited esophageal squamous cell carcinoma risk. It reveals how genetic factors influence gene expression post-transcriptionally in these cells.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Esophageal squamous cell carcinoma (ESCC) is a significant global health concern with a complex genetic component.
- Understanding the cellular basis of inherited cancer risk is crucial for developing targeted prevention and treatment strategies.
Purpose of the Study:
- To pinpoint the specific cellular contexts contributing to inherited risk of esophageal squamous cell carcinoma.
- To elucidate the regulatory mechanisms, particularly post-transcriptional regulation, that mediate genetic susceptibility to ESCC.
Main Methods:
- Integration of single-cell expression quantitative trait loci (eQTL) mapping with large-scale genetic association analyses.
- Analysis of genetic variants to identify their impact on gene expression in specific cell types within the esophageal tissue.
Main Results:
- Invasive epithelial cells were identified as a critical cellular state associated with inherited ESCC susceptibility signals.
- The study uncovered evidence of post-transcriptional regulatory mechanisms playing a role in genetic susceptibility to ESCC.
- Specific cellular contexts were implicated in mediating the effects of germline genetic risk factors.
Conclusions:
- Inherited risk for esophageal squamous cell carcinoma is significantly influenced by genetic factors acting within invasive epithelial cells.
- Post-transcriptional regulation represents a key mechanism through which genetic predisposition to ESCC is manifested at the cellular level.
- This research provides a cellular and molecular framework for understanding the genetic architecture of ESCC susceptibility.
Related Concept Videos
01:14Maintenance of the ES Cell State
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...